Literature DB >> 11004846

[Proangiogenic cytokines (bFGF and VEGF) in BALF from two different lung segments examined by high resolution computed tomography (HRCT) in patients with sarcoidosis].

D Ziora1, S Dworniczak, G Niepsuj, K Niepsuj, W Jarosz, E Sielska-Sytek, K Ciekalska, K Oklek.   

Abstract

The aim of the study was to evaluate the concentrations of bFGF and VEGF in double BAL (2 x 120 ml) from two different lung segments: (s.A) from upper lobe with the most and (s.B) from lower lobe with the least extensive involvement estimated by high resolution computed tomography (HRCT). Examined group consisted of 28 sarcoid patients with homogeneous, regular distribution of nodular opacities in conventional chest X-ray (14 F, 14 M aged 19-54). Eleven healthy volunteers served as controls. In patients with sarcoidosis we observed the significantly higher levels (p < 0.01) of bFGF (1.79 pg/ml, 1.48 pg/ml) and VEGF (107.5 pg/ml, 109.7 pg/ml) in BAL from s.A and s.B respectively in comparison with BAL from lung segments Abis and Bbis in control group (bFGF: 0.75 pg/ml, 0.47 pg/ml and VEGF: 33.7 pg/ml, 43.9 pg/ml respectively). bFGF in BAL from s.A in active sarcoidosis was higher than in s.A and s.B in non-active sarcoidosis. Concentrations of bFGF in BAL from both s.A and s.B correlated positively with CD4/CD8 ratio and absolute number of lymphocytes, CD4 cells and lymphocytes HLA-DR estimated in BAL from these lung segments. We conclude that bFGF and VEGF may be involved in sarcoidosis pathogenesis and bFGF may be useful in estimation of sarcoidosis activity.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11004846

Source DB:  PubMed          Journal:  Pneumonol Alergol Pol        ISSN: 0867-7077


  2 in total

1.  Circulating concentration of markers of angiogenic activity in patients with sarcoidosis and idiopathic pulmonary fibrosis.

Authors:  Dariusz Ziora; Dariusz Jastrzębski; Mariusz Adamek; Zenon Czuba; Jerzy J Kozielski; Alicja Grzanka; Alicja Kasperska-Zajac
Journal:  BMC Pulm Med       Date:  2015-10-05       Impact factor: 3.317

2.  Immunoexpression of TGF-β/Smad and VEGF-A proteins in serum and BAL fluid of sarcoidosis patients.

Authors:  Wojciech J Piotrowski; Justyna Kiszałkiewicz; Paweł Górski; Adam Antczak; Witold Górski; Dorota Pastuszak-Lewandoska; Monika Migdalska-Sęk; Daria Domańska-Senderowska; Ewa Nawrot; Karolina H Czarnecka; Zofia Kurmanowska; Ewa Brzeziańska-Lasota
Journal:  BMC Immunol       Date:  2015-10-06       Impact factor: 3.615

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.